Abstract:Objective: To explore the effect of xylo-oligosaccharides on intestinal bacterial diversity in mice with spleen deficiency constipation. Methods: The 16S rDNA sequencing was used to identify microbiota composition in four groups, including the normal group (NG), the model group with spleen-deficiency constipation (SDC), XOS treated groups that include XOS1 groups treated XOS 0.05 g/mL•d, and XOS2 group treated XOS 0.1 g/mL•d. Chao1 and Shannon were used to conduct gut microbes diversity analysis. Linear discriminant analysis coupled with effect size measurements (LEfSe) was used to identify signature gut microbiota, and phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt) was used to predict the function of altered gut microbiota. Results: Veen map indicated 245 common OTUs were identified from four groups. Especially, 9, 3, 0, and 19 unique OTUs were identified in NG, SDC, XOS1, and XOS2 groups, respectively. The Shannon index was evidently higher in NG group than in the other three groups ( p < 0.05). We identified the occurrence of dominant bacterial groups including Bacteroidetes (25.5 ~ 49.9%), Firmicutes (25.4 ~ 39.3%), Proteobacteria (12.5 ~ 24.9%), Deferribacteres (1.6 ~ 19.2%), Cyanobacteria (0.3 ~ 1.8%), Verrucomicrobia (0.02 ~ 1.6%), Actinobacteria (0.01 ~ 0.5%), and Tenericutes (0.03 ~ 0.09%) at the four groups. The XOS2 group was characterized by a higher abundance of Peptostreptococcaceae , Intestinibacter , Aerococcaceae , and Facklamia . XOS1 group enriched in Deferribacteres , Mucispirillum , Deferribacterales , Deferribacteres , Lachnoclostridium , Rhodospirillaceae , and Rhodospirillales . Meanwhile, the SDC mice showed dramatic enrichment in Rikenellaceae , Lachnospiraceae , Rikenellaceae , Roseburia , and Alistipes , which were highly abundant in the NG group. XOS fed-mice evidently increase Deferribcteres abundance compared with NG and SDC groups. However, the abundance of Rikenellaceae was significantly reduced in XOS1 and XOS2 groups compared with NG and SDC groups. We identified that altered gut microbiotas by XOS treatment were associated with various metabolic pathways, including organismal systems, metabolism, human diseases, genetic information processing, and cellular processes. Conclusion: Our research indicated that XOS has the potential to recover intestinal bacteria and contribute to the treatment of spleen deficiency constipation.

Effects of Xylooligosaccharides on Lipid Metabolism, Inflammation, and Gut Microbiota in C57BL/6J Mice Fed a High-Fat Diet

Effects of Xylo-Oligosaccharide on the Gut Microbiota of Patients with Ulcerative Colitis in Clinical Remission

Effects of xylo-oligosaccharide on gut microbiota, brain protein expression, and lipid profile induced by high-fat diet

Xylooligosaccharides Increase Bifidobacteria and Lachnospiraceae in Mice on a High-Fat Diet, with a Concomitant Increase in Short-Chain Fatty Acids, Especially Butyric Acid

Prebiotic Oligosaccharides Change the Concentrations of Short-Chain Fatty Acids and the Microbial Population of Mouse Bowel.

Prebiotic Xylo-Oligosaccharides Ameliorate High-Fat-Diet-Induced Hepatic Steatosis in Rats

Cooperative action of non-digestible oligosaccharides improves lipid metabolism of high-fat diet-induced mice

Effects of a Galacto-Oligosaccharide-rich Diet on Fecal Microbiota and Metabolite Profiles in Mice.

Effect of xylo-oligosaccharides on intestinal bacterial diversity in mice with spleen deficiency constipation

Xylooligosaccharides (XOS) Ameliorate Insulin Resistance by Increasing Akkermansia Muciniphila and Improving Intestinal Barrier Dysfunction in Gestational Diabetes Mellitus (GDM) Mice

Dose-dependent effects of xylooligosaccharides on glycemic regulation with L. rhamnosus CCFM1060 in diabetic mice

Xylooligosaccharides Ameliorate Insulin Resistance by Increasing Akkermansia Muciniphila and Improving Intestinal Barrier Dysfunction in Gestational Diabetes Mellitus Mice.

Tamarind Xyloglucan Oligosaccharides Attenuate Metabolic Disorders via the Gut–Liver Axis in Mice with High-Fat-Diet-Induced Obesity

Xanthan Gum Oligosaccharides Ameliorate Glucose Metabolism and Related Gut Microbiota Dysbiosis in Type 2 Diabetic Mice

Effects of xylo-oligosaccharide on growth performance, serum biochemical,immune indexes and fecal bacterial community in fattening pigs

Xylo-oligosaccharide Alleviates Salmonella Induced Inflammation by Stimulating Bifidobacterium Animalis and Inhibiting Salmonella Colonization.

Effects of Dietary Xylooligosaccharide Prebiotic Supplementation on Growth, Antioxidant and Intestinal Immune-Related Genes Expression in Common Carp Cyprinus Carpio Fed a High-Fat Diet

Xyloglucan affects gut-liver circulating bile acid metabolism to improve liver damage in mice fed with high-fat diet

Administration of Xylo‐oligosaccharides Improves Depressive‐like Behaviour in Mice Caused by Chronic Unpredictable Mild Stress by Altering Microbiota Composition

Orally Administered Xylo-Oligosaccharides (XOS) Ameliorates Diarrhea Symptoms in Mice Via Intestinal Barrier Improvement and Gut Microbiota Modulation.

The High Level of Xylooligosaccharides Improves Growth Performance in Weaned Piglets by Increasing Antioxidant Activity, Enhancing Immune Function, and Modulating Gut Microbiota.